APA (7th ed.) Citation

C, W., M, L., Y, Y., Y, L., Y, L., Y, Z., . . . Q, W. (2026). SMARCA4 promotes lineage plasticity and enzalutamide resistance in prostate cancer by regulating PROX1 via H3K27 acetylation. Cell death discovery, 12(1), . https://doi.org/10.1038/s41420-026-03068-0

Chicago Style (17th ed.) Citation

C, Wu, et al. "SMARCA4 Promotes Lineage Plasticity and Enzalutamide Resistance in Prostate Cancer by Regulating PROX1 via H3K27 Acetylation." Cell Death Discovery 12, no. 1 (2026). https://doi.org/10.1038/s41420-026-03068-0.

MLA (9th ed.) Citation

C, Wu, et al. "SMARCA4 Promotes Lineage Plasticity and Enzalutamide Resistance in Prostate Cancer by Regulating PROX1 via H3K27 Acetylation." Cell Death Discovery, vol. 12, no. 1, 2026, https://doi.org/10.1038/s41420-026-03068-0.